Reckitt Benckiser Group (LON:RKT) Hits New 12-Month Low at $4,102.64

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Shares of Reckitt Benckiser Group plc (LON:RKT - Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as GBX 4,102.64 ($51.50) and last traded at GBX 4,220 ($52.98), with a volume of 4075005 shares trading hands. The stock had previously closed at GBX 4,275 ($53.67).

Reckitt Benckiser Group Price Performance

The stock has a fifty day moving average of GBX 5,248.50 and a two-hundred day moving average of GBX 5,465.39. The stock has a market capitalization of £29.91 billion, a price-to-earnings ratio of 1,850.88, a PEG ratio of 3.84 and a beta of 0.07. The company has a current ratio of 0.64, a quick ratio of 0.46 and a debt-to-equity ratio of 100.80.

Reckitt Benckiser Group Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 24th. Stockholders of record on Thursday, April 11th will be paid a GBX 115.90 ($1.45) dividend. This is a boost from Reckitt Benckiser Group's previous dividend of $76.60. This represents a dividend yield of 1.99%. The ex-dividend date is Thursday, April 11th. Reckitt Benckiser Group's dividend payout ratio (DPR) is 8,464.91%.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.

Featured Articles


This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Urgent Nvidia Warning (From Altimetry) (Ad)

Should you invest $1,000 in Reckitt Benckiser Group right now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: